PubMedCrossRef 29. Chan C, Burrows Ipilimumab mouse LL, Deber CM: Helix induction in antimicrobial peptides by alginate in biofilms. J Biol Chem 2004, 279:38749–38754.PubMedCrossRef 30. Pacor S, Giangaspero A, Bacac M, Sava G, Tossi A: Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications

for systemic use. J Antimicrob Chemother 2002, 50:339–348.PubMedCrossRef 31. Hoiby N: Pseudomonas in cystic fibrosis: past, present, and future. Cystic Fibrosis Trust, London, United Kingdom; 1998. 32. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318–1322.PubMedCrossRef 33. Hell E, Giske CG, Nelson A, Romling U, Marchini G: Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis. Lett Appl Microbiol 2010, 50:211–215.PubMedCrossRef 34. Batoni G, Maisetta G, Brancatisano FL, Esin S, Campa M: Use of antimicrobial AZD1208 solubility dmso peptides against microbial biofilms: advantages and limits. Curr Med Chem 2011, 18:256–279.PubMedCrossRef 35. Bjarnsholt T, Jensen PO, Fiandaca MJ, Pedersen J, Hansen CR, Andersen CB,

Pressler T, Givskov M, Hoiby N: Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 2009, 44:547–558.PubMedCrossRef 36. Montanaro L, Poggi A, Visai L, Ravaioli S, Campoccia D, Speziale P, Arciola CR: Extracellular DNA in biofilms. Int J Artif Organs 2011, 34:824–831.PubMedCrossRef 37. Barken KB, Pamp SJ, Yang L, Gjermansen M, Bertrand JJ, Klausen M, Givskov M, Whitchurch CB, Engel JN, Tolker-Nielsen T: Roles of type IV pili, flagellum-mediated motility and extracellular DNA in the formation of mature multicellular structures

in Pseudomonas aeruginosa biofilms. Environ Microbiol 2008, 10:2331–2343.PubMedCrossRef 38. Hale JD, Hancock RE: Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti Infect Ther 2007, 5:951–959.PubMedCrossRef 39. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility texting; sixteenth informational supplement. Clinical and Laboratory Standards Institute, ID-8  ; 2010. 40. Gherardi G, De Florio L, Lorino G, Fico L, Dicuonzo G: Macrolide resistance genotypes and phenotypes among erythromycin-resistant clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci, Italy. FEMS Immunol Med Microbiol 2009, 55:62–67.PubMedCrossRef 41. Pompilio A, Pomponio S, Crocetta V, Gherardi G, Verginelli F, Fiscarelli E, Dicuonzo G, Savini V, D’Antonio D, Di Bonaventura G: Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. BMC Microbiol 2011, 11:159.PubMedCrossRef 42. Waddell WJ: A simple ultraviolet spectrophotometric method for the determination of protein. J Lab Clin Med 1956, 48:311–314.PubMed 43.